ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 979

What Have We Learned from Trajectory Analysis of Clinical Outcomes in Osteoarthritis?

Maud Wieczorek1, Anne-Christine Rat1,2,3, Francis Guillemin1,2 and Christine Rotonda1, 1Université de Lorraine, EA4360, APEMAC, Nancy, France, 2Inserm, CIC-1433 Epidémiologie Clinique, Vandoeuvre-lès-Nancy, France, 3Rheumatology Department, CHRU Nancy, Vandoeuvre-lès-Nancy, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Hip, Knee and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Epidemiology and Public Health Poster II: Rheumatic Diseases Other than Rheumatoid Arthritis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The aims of this review were to summarize the literature on the trajectories of clinical outcomes in knee and hip OA, to describe the distinct trajectories for each outcome and to collect the predictive factors associated with these trajectories.

Methods: The Medline database was searched for relevant studies. Selection criteria were: i) patients >= 18 years old, ii) patients at high risk of, or diagnosed with, knee or hip OA, iii) studies aiming to identify homogeneous subgroups with distinct trajectories of clinical outcomes, iv) methodology and analysis designed to identify trajectories (longitudinal design and repeated measures). Articles selection was made independently and in duplicate by two reviewers while the final selection was made independently by three reviewers based on the full text.

Results: Of the 3867 abstracts retrieved, 37 studies met inclusion criteria among which 15 other studies analyzed trajectories before surgery. The other 22 studies focused specifically on the course of clinical outcomes after hip or knee arthroplasty. The most frequent outcome reported in the papers was pain (28 studies) while 19 studies reported results on function, 5 on mental health, 1 on stiffness, 3 on social participation and 1 on activity limitation.  In the cohort studies without surgery, hip pain trajectories were divided in stable mild, moderate and severe pain. 3 additional subgroups included patients who underwent a moderate pain regression, oscillated between moderate and severe pain levels or highly progressed over time (Fig). A low educational level, high body mass index (BMI), an impaired physical function WOMAC score, high Kellgren (KL) grade for the hip, a limited flexion and internal rotation of the hip and concurrent back and trochanteric pain were associated with the membership in the severe pain trajectory. For the knee joint, the number of trajectories identified in the literature was between 1 and 6. A “no pain”, a mild pain, a moderate pain and a severe pain trajectories were identified as well as pain progression (moderate or severe worsening) or regression (major or moderate improvement) trajectories. Patients belonging to the severe pain trajectory were more likely to be male, have a younger age , a low educational level, a low social class, a high BMI, a high number of comorbidities, a high WOMAC physical function score, a high KL grade, higher levels of anxiety and depression, and a poorer general health.

Conclusion: This review highlighted the high heterogeneity across studies in terms of numbers of trajectories retrieved, especially for the pain outcomes. Nonetheless, some predictive factors of membership in a severe pain trajectory have been identified and these findings could be an aid to an early identification of patients with a high risk of clinical worsening.

 


Disclosure: M. Wieczorek, None; A. C. Rat, None; F. Guillemin, None; C. Rotonda, None.

To cite this abstract in AMA style:

Wieczorek M, Rat AC, Guillemin F, Rotonda C. What Have We Learned from Trajectory Analysis of Clinical Outcomes in Osteoarthritis? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/what-have-we-learned-from-trajectory-analysis-of-clinical-outcomes-in-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/what-have-we-learned-from-trajectory-analysis-of-clinical-outcomes-in-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology